Altre lingue Sangui Biotech International, Inc.

Azioni

SBH

US80105B1017

Prezzo di chiusura Hanseatische Wertpapierboerse Hamburg Altri mercati azionari 00:00:00 20/03/2024			Variaz. 5gg	Var. 1 gen.
0,002 ^EUR	-20,00%		-.--%	-33,33%

15/02	Sangui Biotech International, Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 dicembre 2023	CI
2023	Sangui Biotech International, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	15/02
Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	15/11
Sangui BioTech International Inc.: Significant increase in sales in the first three quarters of the year - Further reduction of the operating loss	15/05/23
Sangui BioTech International Inc.: Deutliche Umsatzsteigerung von 20% in den ersten drei Quartalen - Weitere Verminderung des operativen Verlustes	15/05/23
Sangui BioTech International Inc.: Deutliche Umsatzsteigerung von 20% in den ersten drei Quartalen - Weitere Verminderung des operativen Verlustes	15/05/23
Sangui Biotech International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	12/05/23
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year - Further reduction of the operating loss	13/02/23
Sangui BioTech International Inc.: - Deutliche Umsatzsteigerung von 27% im ersten Halbjahr - Weitere Verminderung des operativen Verlustes	13/02/23
Sangui BioTech International Inc.: - Deutliche Umsatzsteigerung von 27% im ersten Halbjahr - Weitere Verminderung des operativen Verlustes	13/02/23
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	07/02/23
Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	07/02/23
Sangui BioTech International Inc.: - Umsätze von USD 41.029 im ersten Quartal - Erstmals positives Quartalsergebnis in der Unternehmensgeschichte	11/11/22
Sangui BioTech International Inc.: - Sales of USD 41,029 in first quarter - For the first time, positive quarterly result in the company's history	11/11/22
Sangui BioTech International Inc.: - Umsätze von USD 41.029 im ersten Quartal - Erstmals positives Quartalsergebnis in der Unternehmensgeschichte	11/11/22
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22
Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	10/11/22
SANGUI BIOTECH INTERNATIONAL INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	03/11/22
Sangui BioTech International Inc.: Umsatzsteigerung im ersten Quartal von 121% - Höchster Quartalsumsatz der Unternehmensgeschichte	12/10/22
Sangui BioTech International Inc.: Umsatzsteigerung im ersten Quartal von 121% - Höchster Quartalsumsatz der Unternehmensgeschichte	12/10/22
Sangui BioTech International Inc.: Increase in sales in the first quarter of 121% - Highest quarterly sales in the company's history	12/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Sangui Biotech International, Inc.

Azioni

SBH

US80105B1017

Altre lingue

Filtri